Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium 140 mg Plaster for Acute Limb Injuries
NCT04976088Phase 3Completed
- Sponsor
- Fidia Farmaceutici
- Start
- May 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in pain and inflammation (3 arms), sponsored by Fidia Farmaceutici. Primary endpoint: Change from baseline in Visual Analogue Scale score for pain at rest at Day 4. Started May 2018; status: completed.
02
Drugs
diclofenac
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT04976088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976088.